Neoadjuvant Chemotherapy in a Case of Nonresectable Papillary Squamous Cell Carcinoma of the Palpebral Conjunctiva

• Published in: Ophthalmic plastic and reconstructive surgery Vol. 40; no. 1; p. e4
• Main Authors: Alam, Md Shahid, Sen, Ahana, Biswas, Bivas
• Format: Journal Article
• Language: English
• Published: United States 01.01.2024
• Subjects: Carcinoma, Squamous Cell - pathology; Conjunctiva - pathology; Eye Neoplasms; Eyelid Neoplasms - pathology; Humans; Male; Middle Aged; Neoadjuvant Therapy; Sebaceous Gland Neoplasms - pathology
• ISSN: 1537-2677
• DOI: 10.1097/IOP.0000000000002487

The role of neoadjuvant chemotherapy (NACT) in eyelid and orbital malignancies is not well defined. It has been tried with good success in cases of eyelid sebaceous gland carcinoma but there is very limited literature on its role in cases of ocular surface squamous neoplasia. A 54-year-old man presented with gradually increasing swelling of the right upper eyelid for the past 2 years. On examination, a large friable papillary mass was found covering the entire conjunctival surface (T3N0M0). Incisional biopsy from the mass was suggestive of papillary squamous cell carcinoma. There was no lymph node or distant metastasis as confirmed by whole-body positron emission tomography-CT scan. A trial of NACT (3 cycles of paclitaxel and cisplatin) was given and the mass shrunk in size considerably making it amenable to surgical resection. The conjunctival surface healed completely and there was no recurrence at 1 year of follow up. NACT can be tried in unresectable large ocular surface neoplasia to make the tumor more amenable to surgical resection.